|
FY2025
12 months to Nov 30, 2025
|
FY2024
12 months to Nov 30, 2024
|
FY2023
12 months to Nov 30, 2023
|
FY2022
12 months to Nov 30, 2022
|
FY2021
12 months to Nov 30, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net loss | |||||
| Adjustments: | |||||
| Equity loss – Donlin Gold | |||||
| Share-based compensation | |||||
| Warrant expense (Note 11) | |||||
| Remediation expense | |||||
| Accretion of notes receivable | |||||
| Interest expense on promissory note | |||||
| Gain on sale of mineral property | |||||
| Deferred income tax recovery | |||||
| Change in fair value of marketable securities | |||||
| Foreign exchange (gain) loss | |||||
| Other operating adjustments | |||||
| Net change in operating assets and liabilities (Note 17) | |||||
| Change in operating assets and liabilities | |||||
| Other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Accrued payroll and related benefits | |||||
| Income taxes payable | |||||
| Remediation liability | |||||
| Net cash used in operating activities | |||||
| Investing activities: | |||||
| Proceeds from term deposits | |||||
| Purchases of term deposits | |||||
| Funding of Donlin Gold | |||||
| Investment in Donlin Gold (Note 5) | |||||
| Proceeds from note receivable | |||||
| Proceeds from disposal of equity securities (Note 15) | |||||
| Proceeds from sale of mineral property | |||||
| Other | |||||
| Net cash provided from investing activities | |||||
| Financing activities: | |||||
| Equity issuances (Note 11) | |||||
| Equity issuance costs (Note 11) | |||||
| Withholding tax on share-based compensation | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year |
Loading...
